惠泰医疗: 关于调整2024年度利润分配现金分红总额及资本公积转增股本总额的公告

Core Viewpoint - Shenzhen Huatai Medical Devices Co., Ltd. has announced adjustments to its 2024 profit distribution cash dividend total and capital reserve share increase total due to changes in its total share capital resulting from the completion of the third vesting period of the B-class restricted stock incentive plan [1][2][3] Group 1: Adjusted Profit Distribution and Capital Increase - The adjusted cash dividend distribution is set at RMB 17.50 per 10 shares (including tax) [1][3] - The total cash distribution amount is estimated to be RMB 170,189,064.50 (including tax), based on a total share capital of 97,250,894 shares [1][3][4] - The total capital reserve share increase is calculated to be 43,762,902 shares, increasing the total share capital to 141,013,796 shares [4] Group 2: Reasons for Adjustment - The adjustment is due to the issuance of an additional 168,938 shares following the completion of the third vesting period of the B-class restricted stock incentive plan [2][3] - The total share capital increased from 97,081,956 shares to 97,250,894 shares after the registration of the new shares on May 30, 2025 [2][3]